Article

Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New York

2021-02-25

Abstract excerpt

Recent months have seen surges of SARS-CoV-2 infection across the globe with considerable viral evolution 1-3 . Extensive mutations in the spike protein may threaten efficacy of vaccines and therapeutic monoclonal antibodies 4 . Two signature mutations of concern are E484K, which plays a crucial role in the loss of neutralizing activity of antibodies, and N501Y, a driver of rapid worldwide transmission of the B.1....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 68619315-0e8f-5194-b8b1-e4f4cbe0668e
DOI: 10.1101/2021.02.23.21252259

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New YorkDOI 10.1101/2021.02.23.21252259Read

Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York.Semantic proximity Read

Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York.Semantic proximity Read

Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations.Semantic proximity Read

Epidemiological characteristics of the B.1.526 SARS-CoV-2 variantSemantic proximity Read

Emergence of the E484K Mutation in SARS-CoV-2 Lineage B.1.1.220 in Upstate New YorkSemantic proximity Read

Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variantsSemantic proximity Read

The rise and fall of an emerging SARS-CoV-2 variant with the spike protein mutation L452RSemantic proximity Read

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodiesSemantic proximity Read

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.Semantic proximity Read

Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2Semantic proximity Read

Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico.Semantic proximity Read

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionSemantic proximity Read